The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.

Tanzhu, Guilong; Chen, Liu; Xiao, Gang; Shi, Wen; Peng, Haiqin; Chen, Dikang; Zhou, Rongrong

Tanzhu, Guilong; Chen, Liu; Xiao, Gang; Shi, Wen; Peng, Haiqin; Chen, Dikang; Zhou, Rongrong.

Afiliação

Tanzhu G; Department of Oncology, Xiangya Hospital, Central South University, 410008, Changsha, China.
Chen L; Department of Oncology, Xiangya Hospital, Central South University, 410008, Changsha, China.
Xiao G; Department of Oncology, Xiangya Hospital, Central South University, 410008, Changsha, China.
Shi W; Department of Oncology, Xiangya Hospital, Central South University, 410008, Changsha, China.
Peng H; Department of Oncology, Xiangya Hospital, Central South University, 410008, Changsha, China.
Chen D; Hunan An Tai Kang Cheng Biotechnology Co., Ltd, Changsha, China.
Zhou R; Department of Oncology, Xiangya Hospital, Central South University, 410008, Changsha, China. zhourr@csu.edu.cn.

Cell Death Discov ; 8(1): 416, 2022 Oct 11.

Article em En | MEDLINE | ID: mdl-36220835

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tratamento / Radioterapia Base de dados: MEDLINE Idioma: En Revista: Cell Death Discov Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google